NCT04819399 2022-04-05Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBCLindis Biotech GmbHPhase 1 Unknown30 enrolled
NCT00959868 2012-02-13A Study for Treatment of Superficial Bladder Cancer Using OGX-427Vancouver Coastal HealthPhase 1 Unknown36 enrolled
NCT00109655 2008-10-03Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) FailureCell GenesysPhase 1 Unknown75 enrolled